The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients
1 other identifier
interventional
57
1 country
1
Brief Summary
The addition of probiotics to the routine therapy of Acute Pharyngotonsillitis in adult patients may shorten the duration, and reduce the severity of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Oct 2012
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2012
CompletedFirst Posted
Study publicly available on registry
September 6, 2012
CompletedStudy Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedOctober 22, 2014
November 1, 2011
11 months
August 16, 2012
October 21, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
period of disease
Patients will be followed daily while hospitalized. After discharge patients will fill a daily dairy for 10 days and record symptoms, signs, drinking, eating, and return to normal life. All dairies will be collected on day 10 of the study.
10 days
Secondary Outcomes (1)
analysis
10 days
Study Arms (3)
Penicillin G
NO INTERVENTIONhospitalization of 30 patients given penicilline intraveniously for 72 hours
Placebo
PLACEBO COMPARATOR30 hospitalized patients will be given placebo with a regular penicillin treatment
Probiotic
EXPERIMENTALProbiotics will be given to 30 hospitalized patients with regular penicillin treatment
Interventions
Eligibility Criteria
You may qualify if:
- Age over 18 years
- Acute pharyngotonsillitis for which hospitalization for intravenous antibiotic treatment and/or fluids is needed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ziv Hospitallead
Study Sites (1)
Ziv Medical Center
Safed, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leonid Livshits, MD
Ziv Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2012
First Posted
September 6, 2012
Study Start
October 1, 2012
Primary Completion
September 1, 2013
Study Completion
October 1, 2013
Last Updated
October 22, 2014
Record last verified: 2011-11